Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

BACKGROUND: In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZV(IN)) was well tolerated and efficacious against herpes zoster (HZ) in autologous hematopoietic stem cell transplant (auto-HSCT) recipients and patients with solid tumor malignancies receiving chemotherapy (STMc) but...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeckh, Michael J, Arvin, Ann M, Mullane, Kathleen M, Camacho, Luis H, Winston, Drew J, Morrison, Vicki A, Hurtado, Kimberly, Durrand Hall, Jessie, Pang, Lei, Su, Shu-Chih, Kaplan, Susan S, Annunziato, Paula W, Popmihajlov, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336559/
https://www.ncbi.nlm.nih.gov/pubmed/32665955
http://dx.doi.org/10.1093/ofid/ofaa172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336559/
https://www.ncbi.nlm.nih.gov/pubmed/32665955
http://dx.doi.org/10.1093/ofid/ofaa172

Ejemplares similares